Company profile for Acousia Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Acousia strives to keep people connected by combatting hearing loss Acousia is committed to identifying and developing novel compounds (small molecules) to preserve and enhance natural hearing for patients suffering from sensorineural hearing loss (SNHL), which make up over 90 percent of those affected by hearing loss. The company aims to make hearing loss treatable for the growing number of people affected so they can stay c...
Acousia strives to keep people connected by combatting hearing loss Acousia is committed to identifying and developing novel compounds (small molecules) to preserve and enhance natural hearing for patients suffering from sensorineural hearing loss (SNHL), which make up over 90 percent of those affected by hearing loss. The company aims to make hearing loss treatable for the growing number of people affected so they can stay connected and fully participate in life.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Germany
Address
Address
Sindelfinger Straße 3 72070 Tübingen
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/acousia-therapeutics-to-present-its-clinical-phase-2-prohear-study-on-hearing-loss-treatment-candidate-acou085-at-upcoming-conferences-302218879.html

PR NEWSWIRE
12 Aug 2024

https://www.prnewswire.com/news-releases/acousia-therapeutics-attracts-new-investor-on-its-path-to-make-hearing-loss-a-treatable-disease-302028577.html

PR NEWSWIRE
09 Jan 2024

https://www.prnewswire.com/news-releases/hearing-loss-company-acousia-therapeutics-to-present-key-learnings-and-data-from-lead-development-programs-at-us-and-european-meetings-in-august-and-september-301906751.html

PR NEWSWIRE
23 Aug 2023

https://www.prnewswire.com/news-releases/hearing-loss-company-acousia-therapeutics-completes-clinical-phase-1-study-with-its-small-molecule-301698445.html

PRNEWSWIRE
12 Dec 2022

https://www.prnewswire.com/news-releases/hearing-loss-company-acousia-therapeutics-completes-clinical-phase-1-study-with-its-small-molecule-301698451.html

PRNEWSWIRE
12 Dec 2022

https://www.prnewswire.com/news-releases/hearing-loss-company-acousia-therapeutics-to-present-data-for-lead-candidates-acou085--acou082-at-aro-2023-midwinter-meeting-february-1115-301686563.html

PRNEWSWIRE
24 Nov 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty